Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The VPAC1 receptor: structure and function of a class B GPCR prototype.

Couvineau A, Ceraudo E, Tan YV, Nicole P, Laburthe M.

Front Endocrinol (Lausanne). 2012 Nov 16;3:139. doi: 10.3389/fendo.2012.00139. eCollection 2012.

2.

VPAC1 receptor binding site: contribution of photoaffinity labeling approach.

Couvineau A, Ceraudo E, Tan YV, Laburthe M.

Neuropeptides. 2010 Apr;44(2):127-32. doi: 10.1016/j.npep.2009.11.008. Epub 2009 Dec 23. Review.

PMID:
20031208
3.

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.

Couvineau A, Laburthe M.

Br J Pharmacol. 2012 May;166(1):42-50. doi: 10.1111/j.1476-5381.2011.01676.x. Review.

4.

Strategies for studying the ligand binding site of GPCRs: photoaffinity labeling of the VPAC1 receptor, a prototype of class B GPCRs.

Couvineau A, Tan YV, Ceraudo E, Laburthe M.

Methods Enzymol. 2013;520:219-37. doi: 10.1016/B978-0-12-391861-1.00010-1.

PMID:
23332702
5.

The human VPAC1 receptor: identification of the N-terminal ectodomain as a major VIP-binding site by photoaffinity labeling and 3D modeling.

Couvineau A, Tan YV, Ceraudo E, Lacapère JJ, Murail S, Neumann JM, Laburthe M.

Ann N Y Acad Sci. 2006 Jul;1070:205-9.

PMID:
16888167
7.

The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor.

Ceraudo E, Tan YV, Nicole P, Couvineau A, Laburthe M.

J Mol Neurosci. 2008 Nov;36(1-3):245-8. doi: 10.1007/s12031-008-9073-7. Epub 2008 Jul 3.

PMID:
18597186
8.

Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.

Ceraudo E, Hierso R, Tan YV, Murail S, Rouyer-Fessard C, Nicole P, Robert JC, Jamin N, Neumann JM, Robberecht P, Laburthe M, Couvineau A.

FASEB J. 2012 May;26(5):2060-71. doi: 10.1096/fj.11-196444. Epub 2012 Jan 30.

PMID:
22291440
9.

Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling.

Tan YV, Couvineau A, Murail S, Ceraudo E, Neumann JM, Lacapère JJ, Laburthe M.

J Biol Chem. 2006 May 5;281(18):12792-8. Epub 2006 Mar 6.

11.

Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor.

Ceraudo E, Tan YV, Couvineau A, Lacapere JJ, Laburthe M.

Ann N Y Acad Sci. 2006 Jul;1070:180-4.

PMID:
16888162
12.

Production and purification of large quantities of the functional N-terminal ectodomain of human VPAC1 receptor.

Couvineau A, Robert JC, Ramdani T, Lacapère JJ, Rouyer-Fessard C, Laburthe M.

J Mol Neurosci. 2008 Nov;36(1-3):249-53. doi: 10.1007/s12031-008-9072-8. Epub 2008 Jul 1.

PMID:
18592417
13.

Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.

Marie JC, Rouyer-Fessard C, Couvineau A, Nicole P, Devaud H, El Benna J, Laburthe M.

Mol Pharmacol. 2003 Dec;64(6):1565-74.

14.

Characterization of the new photoaffinity probe (Bz2-K24)-VIP.

Tan YV, Couvineau A, Lacapere JJ, Laburthe M.

Ann N Y Acad Sci. 2006 Jul;1070:575-80.

PMID:
16888228
15.

Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor.

Tan YV, Couvineau A, Van Rampelbergh J, Laburthe M.

J Biol Chem. 2003 Sep 19;278(38):36531-6. Epub 2003 Jun 13.

16.

Human VPAC1 receptor selectivity filter. Identification of a critical domain for restricting secretin binding.

Du K, Couvineau A, Rouyer-Fessard C, Nicole P, Laburthe M.

J Biol Chem. 2002 Oct 4;277(40):37016-22. Epub 2002 Jul 19.

17.

The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain.

Lins L, Couvineau A, Rouyer-Fessard C, Nicole P, Maoret JJ, Benhamed M, Brasseur R, Thomas A, Laburthe M.

J Biol Chem. 2001 Mar 30;276(13):10153-60. Epub 2000 Dec 21.

18.

The family B1 GPCR: structural aspects and interaction with accessory proteins.

Couvineau A, Laburthe M.

Curr Drug Targets. 2012 Jan;13(1):103-15. Review.

PMID:
21777182
19.
20.

Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology.

Laburthe M, Couvineau A, Tan V.

Peptides. 2007 Sep;28(9):1631-9. Epub 2007 May 22. Review.

PMID:
17574305

Supplemental Content

Support Center